
================================================================================
=== DOCUMENT 1: 8-K - tm2416068d1_8k.htm ===
================================================================================

false
--12-31
0001075415
0001075415
2024-05-31
2024-05-31
0001075415
us-gaap:CommonStockMember
2024-05-31
2024-05-31
0001075415
DHC:SeniorNotesDue2042Member
2024-05-31
2024-05-31
0001075415
DHC:SeniorNotesDue2046Member
2024-05-31
2024-05-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 31, 2024
Diversified Healthcare Trust
(Exact Name of Registrant as Specified in
Its Charter)
Maryland
(State or Other Jurisdiction of Incorporation)
001-15319
04-3445278
(Commission File Number)
(IRS Employer Identification No.)
Two Newton Place
,
255 Washington Street
,
Suite 300
Newton
,
Massachusetts
02458-1634
(Address of Principal Executive Offices)
(Zip Code)
617
-
796-8350
(Registrant’s Telephone Number, Including
Area Code)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title Of Each Class
Trading Symbol(s)
Name Of Each Exchange
On
Which Registered
Common
Shares of Beneficial Interest
DHC
The
Nasdaq Stock Market LLC
5.625%
Senior Notes due 2042
DHCNI
The
Nasdaq Stock Market LLC
6.25%
Senior Notes due 2046
DHCNL
The
Nasdaq Stock Market LLC
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
In this Current Report on Form 8-K, the
terms “we”, “us”, “our” and “the Company” refer to Diversified Healthcare Trust.
Item
5.03.
Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year
On May 31, 2024, our Board of Trustees (the
“Board”) approved and adopted our Fourth Amended and Restated Bylaws (the “Amended Bylaws”), to (1) eliminate
provisions which, subject to certain exceptions, allowed for the resolution of disputes, claims or controversies brought by a shareholder
against us or any Trustee, officer, manager, agent or employee of us on such shareholder’s own behalf, on behalf of us or on behalf
of any series or class of shares or shareholders, including derivative and class actions, through binding and final arbitration in accordance
with specified procedures, and (2) make certain clarifying, administrative and conforming changes.
The foregoing description of our Amended Bylaws
is not complete and is subject to and qualified in its entirety by reference to the Amended Bylaws, a copy of which is filed as Exhibit 3.5
to this Current Report on Form 8-K and incorporated herein by reference. In addition, a marked copy of our Amended Bylaws indicating
changes made to our bylaws as they existed immediately prior to the adoption of our Amended Bylaws is filed as Exhibit 3.6 to this
Current Report on Form 8-K.
Item
5.07.
Submission of Matters to
a Vote of Security Holders.
At the Company’s annual meeting of shareholders
held on May 31, 2024 (the “2024 Annual Meeting”), the Company’s shareholders voted on the election of seven Trustees
to the Board each for a one year term of office continuing until the Company’s 2025 annual meeting of shareholders and until her,
his or their respective successor is duly elected and qualifies. The following persons were elected as Trustees and received the following
votes:
Nominee
Votes For
Withhold
Broker
Non-Votes
Christopher J. Bilotto
159,793,584
32,422,061
28,024,770
John L. Harrington
157,753,564
34,462,081
28,024,770
Lisa Harris Jones
148,427,736
43,787,909
28,024,770
Phyllis M. Hollis
160,025,263
32,190,382
28,024,770
Dawn K. Neher
160,315,218
31,900,427
28,024,770
Adam D. Portnoy
131,493,081
60,722,564
28,024,770
Jeffrey P. Somers
142,245,952
49,969,693
28,024,770
The Company’s shareholders also voted on a non-binding advisory
resolution on the compensation paid to the Company’s named executive officers as disclosed pursuant to Item 402 of Regulation S-K
in the Company’s proxy statement relating to the 2024 Annual Meeting. This proposal received the following votes:
For
Against
Abstain
Broker Non-Votes
154,465,115
37,498,438
252,092
28,024,770
The Company’s shareholders also ratified the appointment of Deloitte &
Touche LLP as the Company’s independent auditors to serve for the 2024 fiscal year. This proposal received the following votes:
For
Against
Abstain
Broker Non-Votes
187,203,902
32,665,377
371,136
–
The results reported above are final voting results.
Item
9.01.
Financial Statements and
Exhibits.
Exhibit
Number
Description
3.5
Fourth Amended and Restated Bylaws of the Company, adopted May 31, 2024 (Filed herewith)
3.6
Fourth Amended and Restated Bylaws of the Company, adopted May 31, 2024 (marked copy) (Filed herewith)
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
DIVERSIFIED HEALTHCARE TRUST
By:
/s/ Matthew C. Brown
Name:
Matthew C. Brown
Title:
Chief Financial Officer and Treasurer
Date: June 4, 2024

